Jacob Krall

Jacob Krall is an experienced professional in the pharmaceutical sector, currently serving as Associate Manager in R&D and MS&T Laboratories at Xellia Pharmaceuticals since February 2018, where responsibilities include acting as EHS representative for both Analytical Development and QC laboratories. In previous roles, Jacob held positions such as Senior Research Scientist and Postdoctoral Researcher at the Faculty of Health and Medical Sciences and the Faculty of Pharmaceutical Sciences at the University of Copenhagen. Jacob's educational background includes a Master of Science in Pharmacy from the University of Copenhagen and additional training related to solid-state analysis and chemical classification. During a research visit to the Università degli Studi di Milano, Jacob focused on synthesizing novel analogs of GABAA receptor agonists.